Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Serum Institute of India starts manufacturing Codagenix’s nasal COVID-19 vaccine

Serum Institute of India has started manufacturing COVID-19 vaccine candidate developed by Codagenix Inc, the US biotech firm said in a statement. Dubbed as CDX-005, the coronavirus vaccine candidate has completed pre-clinical animal studies. The company aims to initiate phase I clinical trial of its COVID-19 vaccine in the United Kingdom by the end of […]

The post Serum Institute of India starts manufacturing Codagenix's nasal COVID-19 vaccine first appeared on World Pharma Today.



This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here

Share the post

Serum Institute of India starts manufacturing Codagenix’s nasal COVID-19 vaccine

×

Subscribe to Leading Pharmaceutical Industry Online Platform

Get updates delivered right to your inbox!

Thank you for your subscription

×